CFM
BIOA

Comprehensive Financial Management’s BioAge Labs BIOA Stock Holding History

Comprehensive Financial Management’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.75M Hold
271,842
– – 0.16% 17
2025
Q4 		$3.6M Hold
271,842
– – 0.11% 20
2025
Q3 		$1.6M Hold
271,842
– – 0.04% 26
2025
Q2 		$1.12M Hold
271,842
– – 0.03% 33
2025
Q1 		$1.02M Hold
271,842
– – 0.03% 29
2024
Q4 		$1.57M Hold
271,842
– – 0.04% 25
2024
Q3 		$5.65M Buy
+271,842
New +$5.45M 0.16% 18

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

Comprehensive Financial Management's BIOA Position: Q1 2026 in Review

Comprehensive Financial Management held its BioAge Labs (BIOA) position steady in Q1 2026 at 271,842 shares worth $4.75M. The position accounts for 0.16% of the portfolio, ranked #17.

Comprehensive Financial Management first reported a position in BIOA in Q3 2024 and has held it in 7 quarters since. The position peaked at $5.65M in Q3 2024. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

  • Comprehensive Financial Management held 271,842 shares of BioAge Labs worth $4.75M as of Q1 2026.
  • Comprehensive Financial Management left its BioAge Labs share count unchanged in Q1 2026.
  • BioAge Labs made up 0.16% of Comprehensive Financial Management's portfolio in Q1 2026, its #17 holding.
  • Comprehensive Financial Management first reported a position in BioAge Labs in Q3 2024 and has held it in 7 quarters since.
  • Comprehensive Financial Management's BioAge Labs position peaked at $5.65M in Q3 2024.
  • 144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on Comprehensive Financial Management's 13F filing for Q1 2026, filed 15 May 2026.